ClinConnect ClinConnect Logo
Search / Trial NCT04477447

PMCF Study on the Safety and Performance of CESPACE 3D

Launched by AESCULAP AG · Jul 17, 2020

Trial Information

Current as of July 22, 2025

Completed

Keywords

Cervical Vertebrae; Spondylolisthesis; Treatment Outcome; Interbody Fusion

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient is minimum 18 years old
  • Written informed consent for the documentation of clinical and radiological results
  • Patient's indication according to IFU
  • Patient is not pregnant
  • Exclusion Criteria:
  • • Patient is not willing or able to participate at the follow-up examination

About Aesculap Ag

Aesculap AG is a prominent global medical device manufacturer specializing in surgical instruments, implants, and innovative healthcare solutions. With a rich history rooted in excellence and innovation, Aesculap AG is dedicated to advancing surgical practices through cutting-edge technology and a commitment to improving patient outcomes. The company collaborates with healthcare professionals and institutions to conduct clinical trials that evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of quality and performance. Through its rigorous research and development initiatives, Aesculap AG aims to contribute significantly to the field of medicine and enhance the standards of surgical care worldwide.

Locations

Koblenz, , Germany

Kremmen, , Germany

Patients applied

0 patients applied

Trial Officials

Stefan Nikolaus Kroppenstedt, Dr. med.

Principal Investigator

Abteilung für Wirbelsäulenchirurgie Sana Kliniken Sommerfeld

Francis Kilian, Dr. med.

Principal Investigator

Katholisches Klinikum Koblenz

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials